Patient Monitoring Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Patient Monitoring Devices Market Analysis and It is Segmented by Type of Device (Hemodynamic Monitoring Devices, Neuromonitoring Devices, Cardiac Monitoring Devices, Multi-Parameter Monitors, Respiratory Monitoring Devices, and Other Types of Devices), Application (Cardiology, Neurology, Respiratory, Fetal and Neonatal, Weight Management and Fitness Monitoring, and Other Devices), End User (Home Care Settings, Hospital and Clinics, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Values are Provided in Terms of USD for Above Segments

Patient Monitoring Market Size

Single User License
Team License
Corporate License
Book before:
Patient Monitoring Market Summary
share button
Study Period 2019 - 2029
Market Size (2024) USD 47.05 Billion
Market Size (2029) USD 67.19 Billion
CAGR (2024 - 2029) 7.39 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Patient Monitoring Market Major Players

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

OFF

Team License

OFF

Corporate License

OFF
Book before:

Patient Monitoring Market Analysis

The Patient Monitoring Market size is estimated at USD 47.05 billion in 2024, and is expected to reach USD 67.19 billion by 2029, growing at a CAGR of 7.39% during the forecast period (2024-2029).

The outbreak of the pandemic impacted the patient monitoring market. During the pandemic, the demand for patient monitoring devices such as neuromonitoring, respiratory, and cardiac devices drastically increased due to the need for constant monitoring of COVID-19 patients. For instance, according to the NCBI study published in October 2022, wearable respiratory sensors were widely used during the pandemic as they can monitor biomechanical signals, such as the abnormities in respiratory rate and cough frequency caused by COVID-19, as well as biochemical signals, such as viral biomarkers from exhaled breaths. Thus, the market witnessed healthy growth during the pandemic and is expected to maintain an upward trend over the forecast period.

The growth of the patient monitoring market is attributed to the rising burden of chronic diseases due to lifestyle changes, growth in the geriatric population, growing preference for home and remote monitoring, and the ease of use of portable devices. For instance, according to the June 2022 update of the Centers for Disease Control and Prevention (CDC), one or more chronic diseases, such as diabetes, cancer, heart disease, and stroke, affect six out of ten Americans. These and other chronic illnesses are the main contributors to health care costs and the significant causes of death and disability in the United States. Similarly, according to the data published by the NCBI in April 2022, an estimated 6.5 million Americans aged 65 and older were living with Alzheimer's dementia in 2022. The number is expected to grow to 13.8 million by 2060. Thus, such a high burden of chronic diseases is expected to increase the demand for patient monitoring devices as these diseases require constant monitoring, in which patient monitoring devices come into play. In addition, constant monitoring reduces readmission rates, prevents avoidable hospitalizations, decreases the number of unnecessary trips to the doctor's office, and reduces travel-related expenses. With the proper implementation, patient monitoring technologies can expand access to quality healthcare and save time and money. Thus, considerable market growth is expected over the forecast period due to such factors.

Additionally, initiatives such as expansion and product launches are other factors responsible for the market's growth. For instance, in September 2021, the Indian subsidiary of Medtronic partnered with Stasis Health to expand access to Statis Monitor, a connected care bedside multi-parameter monitoring system across India. Similarly, in July 2021, Terumo Corporation launched Japan's Dexcom G6 continuous glucose monitoring system. Dexcom, Inc., based in the United States, manufactures the product, and Terumo holds the exclusive distribution agreement in Japan. Such developments are likely to bolster the growth of the patient monitoring market over the forecast period.

However, resistance from healthcare industry professionals toward adopting patient monitoring systems and the high cost of technology will likely hinder the market growth over the forecast period.

Patient Monitoring Market Trends

The Cardiology Segment is Expected to Witness Considerable Market Growth Over the Forecast Period

In cardiology, patient monitoring devices are used to diagnose and monitor various disorders or abnormalities of the heart and the overall cardiovascular system. The major factor driving the segment's growth is the rising number of cases and deaths due to cardiovascular diseases and the increasing number of cardiac surgeries. For instance, according to the CDC update in January 2023, around 6.2 million adults in the United States have heart failure yearly. Similarly, according to the journal published by HexaHealth in October 2022, around 2,00,000 surgeries were performed in the United States and 60,000 in India annually. Post-surgery continuous patient monitoring is essential to track any possibility of complications and the recovery rate in which cardiac patient monitoring comes into play. Thus, increasing cardiac surgeries is also expected to surge the segment growth.

Furthermore, product launches and favorable initiatives by the market players in the cardiac monitoring space are also likely to fuel the growth of this segment. For instance, in June 2022, GE Healthcare launched its wireless patient monitoring system, Portrait Mobile. The product helps capture respiration rate, oxygen saturation, and pulse rate for general ward and post-surgery patients continuously, allowing clinicians to act early and avert serious adverse events. Similarly, in January 2021, Boston Scientific Corporation acquired PreventiceSolutions, Inc., a privately held company offering remote and wearable cardiac monitors for adults and pediatric patients. The acquisition will establish a strong footprint for Boston Scientific Corporation in the implantable cardiac monitor market. It is an implantable diagnostic device for detecting arrhythmias. Therefore, owing to the above factors, the segment is anticipated to grow considerably over the forecast period.

Patient Monitoring Market: Estimated Number of Cardiac Surgeries (in thousands) Performed Annually, United States and India, 2022

North America Region Holds a Considerable Market Share Over the Forecast Period

The North American patient monitoring market is expected to witness considerable growth and is estimated to show a similar trend over the forecast period. The increasing geriatric population, rising incidences of chronic diseases, growing demand for wireless and portable systems, and sophisticated reimbursement structures aimed at cutting out-of-pocket expenditure levels are the major factors attributed to its large market share. For instance, according to a report published by the Public Health Agency of Canada in December 2021, the crude incidence rate per 100,000 persons aged 65 years and more for ischemic heart disease was 2,306.9 in men and 1,537 for women and chronic obstructive pulmonary disease was 1,750.6 in men and 1,411.4 in women. In addition, according to the report published by the Canadian Chronic Disease Surveillance System in November 2022, the overall number of adults aged 65 years and older who were to be living with chronic conditions were expected to be about 6.3 million in the coming years. Thus, owing to such instances, considerable market growth is expected over the forecast period.

In the North America, the United States is expected to witness significant growth over the forecast period. The product launches by the key players and product approvals in the country are the major drivers for the market. For instance, in July 2021, Abbott introduced Jot Dx, an insertable cardiac monitor. It is designed to reduce data burden and diagnose abnormal heart rhythms. Similarly, in July 2022, Switzerland-based medical technology company Sleepiz received the U.S. FDA clearance for Sleepiz One+ contactless respiration and heart rate measuring device and was launched in the United States. Sleepiz One+ is one of the first respiratory monitoring devices that non-contactly monitors and records patient data during sleep. Sleepiz technology enables a new perspective on patient health, as doctors no longer rely on random check-up measurements but instead have access to continuous data. Thus, owing to the launch of innovative products and the rising prevalence of chronic diseases in the North American region, the market is expected to witness a high growth rate over the forecast period.

Patient Monitoring Market - Growth Rate by Region

Patient Monitoring Industry Overview

The patient monitoring market is moderately competitive and consists of several major players. The companies are implementing certain strategic initiatives, such as mergers, new product launches, acquisitions, and partnerships, that help strengthen their market position. The key players in the market are Abbott Laboratories, Baxter International Inc., Boston Scientific Corporation, Becton, Dickinson and Company, General Electric Company (GE Healthcare), and Johnson & Johnson, among others.

Patient Monitoring Market Leaders

  1. Abbott Laboratories

  2. Boston Scientific Corporation

  3. GE Healthcare

  4. Johnson & Johnson

  5. Becton, Dickinson and Company

*Disclaimer: Major Players sorted in no particular order

Patient Monitoring Market Concentration
bookmark Need More Details on Market Players and Competitors?
Download PDF

Patient Monitoring Market News

  • April 2023: Honeywell announced that it has developed a real-time health monitoring system, which captures and records patients' vital signs both within the hospital setting and remotely. Honeywell's solution uses advanced sensing technology to monitor vital signs via a skin patch, which connects the data instantaneously to healthcare providers on mobile devices and an online dashboard.
  • January 2023: Senet and Telli Health launched the first remote patient monitoring (RPM) hardware powered by LoRaWAN. This technology will allow providers to reach more patients in remote and underserved areas, such as indigenous communities, globally, boosting healthcare equity and inclusivity and creating the foundation to provide more smart home services in the near future.

Patient Monitoring Devices Market Report - Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Burden of Chronic Diseases due to Lifestyle Changes

      2. 4.2.2 Growing Preference for Home and Remote Monitoring

    3. 4.3 Market Restraints

      1. 4.3.1 Resistance from Healthcare Industry Professionals Toward the Adoption of Patient Monitoring Systems

      2. 4.3.2 High Cost of Technology

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Buyers/Consumers

      2. 4.4.2 Bargaining Power of Suppliers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD)

    1. 5.1 By Type of Device

      1. 5.1.1 Hemodynamic Monitoring Devices

      2. 5.1.2 Neuromonitoring Devices

      3. 5.1.3 Cardiac Monitoring Devices

      4. 5.1.4 Multi-parameter Monitors

      5. 5.1.5 Respiratory Monitoring Devices

      6. 5.1.6 Other Types of Devices

    2. 5.2 By Application

      1. 5.2.1 Cardiology

      2. 5.2.2 Neurology

      3. 5.2.3 Respiratory

      4. 5.2.4 Fetal and Neonatal

      5. 5.2.5 Weight Management and Fitness Monitoring

      6. 5.2.6 Other Applications

    3. 5.3 By End-User

      1. 5.3.1 Home Healthcare

      2. 5.3.2 Hospitals and Clinics

      3. 5.3.3 Other End-Users

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Baxter International Inc.

      3. 6.1.3 Boston Scientific Corporation

      4. 6.1.4 Becton, Dickinson and Company

      5. 6.1.5 General Electric Company (GE Healthcare)

      6. 6.1.6 Johnson & Johnson

      7. 6.1.7 Masimo Corporation

      8. 6.1.8 Medtronic PLC

      9. 6.1.9 Omron Corporation

      10. 6.1.10 Koninklijke Philips NV

      11. 6.1.11 Drägerwerk AG & Co. KGaA

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers- Business Overview, Financials, Products and Strategies, and Recent Developments
bookmark You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Patient Monitoring Industry Segmentation

As per the scope of this report, patient monitoring devices are monitoring devices that continuously monitor the patient's vital parameters, like blood pressure and heart rate, by using a medical monitor and collecting medical (and other) data from individuals. The patient monitoring market is segmented by type of device (hemodynamic monitoring devices, neuromonitoring devices, cardiac monitoring devices, multi-parameter monitors, respiratory monitoring devices, remote patient monitoring devices, and other types of devices), application (cardiology, neurology, respiratory, fetal and neonatal, weight management and fitness monitoring, and other devices), end user (home care settings, hospital and clinics, and other end users), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD) for the segments mentioned above.

By Type of Device
Hemodynamic Monitoring Devices
Neuromonitoring Devices
Cardiac Monitoring Devices
Multi-parameter Monitors
Respiratory Monitoring Devices
Other Types of Devices
By Application
Cardiology
Neurology
Respiratory
Fetal and Neonatal
Weight Management and Fitness Monitoring
Other Applications
By End-User
Home Healthcare
Hospitals and Clinics
Other End-Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
customize-icon Need A Different Region Or Segment?
Customize Now

Patient Monitoring Devices Market Research FAQs

The Patient Monitoring Market size is expected to reach USD 47.05 billion in 2024 and grow at a CAGR of 7.39% to reach USD 67.19 billion by 2029.

In 2024, the Patient Monitoring Market size is expected to reach USD 47.05 billion.

Abbott Laboratories, Boston Scientific Corporation, GE Healthcare, Johnson & Johnson and Becton, Dickinson and Company are the major companies operating in the Patient Monitoring Market.

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).

In 2024, the North America accounts for the largest market share in Patient Monitoring Market.

In 2023, the Patient Monitoring Market size was estimated at USD 43.57 billion. The report covers the Patient Monitoring Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Patient Monitoring Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

Patient Monitoring Devices Industry Report

Statistics for the 2024 Patient Monitoring market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Patient Monitoring analysis includes a market forecast outlook to for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

close-icon
80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

Patient Monitoring Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)